Donate
2024 Believe Walks
New Family
New Family Registration
Subscribe
All Events
Latest News
Shop
Home
Understanding Dup15q
Signs and Symptoms
Diagnosing Dup15q Syndrome
Types of 15q Duplications
Genetics of 15q Duplications
Believe: Living with Dup15q Syndrome Documentary
Glossary
FAQs
Families & Caregivers
Just Diagnosed
Medical & Health Care
Dup15q Clinics
Support for International Dup15q Families
Extended Family & Support
Programs & Resources
Siblings
International Family Conferences
Family Stories
In Loving Memory
Professionals
Clinicians
Health Care Needs
Dup15q Clinics
Common Medications used in Dup15q Syndrome
Research
Scientific Conferences
Current Research Opportunities
Clinical Trials
Published Research
Research News
Grants & Funding
Dup15q Alliance Fellowship Program
CRiSPR & dup15q syndrome
Get Involved
Donate: Ways to Give
Host a Fundraiser
Run/Ride for a Reason
Host a Believe Walk
Volunteer Opportunities
Junior Believe Ambassador
Dup15q Advocacy
About Us
About Us
Board of Directors
Administration
Professional Advisory Board
Partnerships
Annual Report
Policies & Photo Release
Published Research
An unbiased drug screen for seizure suppressors in Dup15q syndrome reveals 5HT1A and dopamine pathway activation as potential therapies
April 13, 2020
An unbiased drug screen for seizure suppressors in Dup15q syndrome reveals 5HT
1A
and dopamine pathway activation as potential therapies
Bidisha
Roy
,
Jungsoo
Han
,
Kevin A.
Hope
,
Tracy L.
Peters
,
Glen
Palmer
,
Lawrence T.
Reiter
doi:
https://doi.org/10.1101/2020.02.18.954560
Abstract